E-LIB Suche - Ergebnisse für: Antoine N. Saliba

1

A phase I study of pevonedistat, azacitidine, and venetocla..:

Murthy, Guru Subramanian Guru ; Saliba, Antoine N. ; Szabo, Aniko...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Prognostic impact of 'multi-hit' versus 'single hit' TP53 a..:

Badar, Talha ; Nanaa, Ahmad ; Atallah, Ehab...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

3

Comparing venetoclax in combination with hypomethylating ag..:

Badar, Talha ; Nanaa, Ahmad ; Atallah, Ehab...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Cardiac events in newly diagnosed acute myeloid leukaemia d..:

Johnson, Isla M. ; Karrar, Omer ; Rana, Masooma...
British Journal of Haematology. 204 (2024) 4 - p. 1232-1237 , 2024

Link: https://doi.org/10.1111/..

5

AMPK inhibition sensitizes acute leukemia cells to BH3 mime..:

Jia, Jia ; Ji, Wenbo ; Saliba, Antoine N....
Cell Death & Differentiation. 31 (2024) 4 - p. 405-416 , 2024

Link: https://doi.org/10.1038/..

6

Cladribine plus cytarabine plus venetoclax in acute myeloid..:

Steinauer, Nickolas ; McCullough, Kristen ; Al-Kali, Aref...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

7

FLT3 inhibitors potentially improve response rates in acute..:

Csizmar, Clifford M. ; Saliba, Antoine N. ; Greipp, Patricia T....
Haematologica. , 2024

Link: https://doi.org/10.3324/..

8

Venetoclax and hypomethylating agent combination therapy in..:

Gangat, Naseema ; Karrar, Omer ; Iftikhar, Moazah...
American Journal of Hematology. 99 (2023) 2 - p. 193-202 , 2023

Link: https://doi.org/10.1002/..

9

Survival of TP53-mutated acute myeloid leukemia patients re..:

Badar, Talha ; Atallah, Ehab ; Shallis, Rory...
Leukemia. 37 (2023) 4 - p. 799-806 , 2023

Link: https://doi.org/10.1038/..

10

Hematological manifestations of antiphospholipid syndrome: ..:

El Hasbani, Georges ; Saliba, Antoine N. ; Uthman, Imad.
Blood Reviews. 58 (2023) - p. 101015 , 2023

Link: https://doi.org/10.1016/..

11

Minimal residual disease in Philadelphia‐positive acute lym..:

Saliba, Antoine N. ; Foà, Robin
American Journal of Hematology. 98 (2023) 8 - p. 1168-1170 , 2023

Link: https://doi.org/10.1002/..

12

Pevonedistat with azacitidine in older patients with TP53-m..:

Saliba, Antoine N. ; Kaufmann, Scott H. ; Stein, Eytan M....
Blood Advances. 7 (2023) 11 - p. 2360-2363 , 2023

Link: https://doi.org/10.1182/..

13

Outcomes of TP53‐mutated AML with evolving frontline therap..:

Badar, Talha ; Atallah, Ehab ; Shallis, Rory M....
American Journal of Hematology. 97 (2022) 7 - p. , 2022

Link: https://doi.org/10.1002/..

14

Disparities in receiving disease‐directed therapy, allogene..:

Badar, Talha ; Litzow, Mark R. ; Shallis, Rory M....
Cancer. 129 (2022) 6 - p. 934-945 , 2022

Link: https://doi.org/10.1002/..

15

Accelerated and blast phase myeloproliferative neoplasms:

Saliba, Antoine N. ; Gangat, Naseema
Best Practice & Research Clinical Haematology. 35 (2022) 2 - p. 101379 , 2022

Link: https://doi.org/10.1016/..